60687-549-21 : NDC 2026 Code

60687-549-21 : Ranolazine ( Ranolazine )

Additionally :

You can get information about “60687-549-21” NDC code in 60687-549-21 in HTML format

HTML | 60687-549-21 in TXT (Plain Text) format

TXT | 60687-549-21 in PDF (Portable Document Format)

PDF | 60687-549-21 in XML format

XML formats.

NDC Code : 60687-549-21 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "60687-549-21",
    "PackageDescription": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-549-21)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-549-11) ",
    "NDC11Code": "60687-0549-21",
    "ProductNDC": "60687-549",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ranolazine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ranolazine",
    "DosageFormName": "TABLET, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20200819",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA210054",
    "LabelerName": "American Health Packaging",
    "SubstanceName": "RANOLAZINE",
    "StrengthNumber": "500",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-10-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20200819",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}